Exelixis, Inc. (EXEL) CEO Mike Morrissey Presents at Barclays Global Healthcare Conference 2020 (Transcript) [Seeking Alpha]
Exelixis, Inc. (EXEL)
Last exelixis, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-mediaresources
Company Research
Source: Seeking Alpha
Exelixis, Inc. (NASDAQ: EXEL Company Participants Mike Morrissey - Chief Executive Officer Conference Call Participants Peter Lawson - Barclays Good afternoon. Welcome to Barclays Global Healthcare Conference. My name is Peter Lawson. I'm one of the biotech analysts at Barclays. It's my great pleasure to introduce Mike Morrissey, CEO of Exelixis. And also, we have Chris Senner, CFO from Exelixis. Maybe, Mike, just as a general introductory question before we get into the main Q&A section, perhaps you could give us a high-level overview of the company, when your lead drug was approved, indications you target. Thank you. Yes, absolutely. Good afternoon, everybody. This is Mike Morrissey. Before I begin today, I'll remind you that I'll be making forward-looking statements today, so please see our SEC filings for a risk -- for a description of the risks that we face in our business. So Exelixis, commercial stage biotech company, focused in the area of oncology. Our main drug is CABOMETYX,
Show less
Read more
Impact Snapshot
Event Time:
EXEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXEL alerts
High impacting Exelixis, Inc. news events
Weekly update
A roundup of the hottest topics
EXEL
News
- 3 Reasons Growth Investors Will Love Exelixis (EXEL) [Yahoo! Finance]Yahoo! Finance
- EXEL vs. CSLLY: Which Stock Is the Better Value Option? [Yahoo! Finance]Yahoo! Finance
- 3 TSX Penny Stocks With Market Caps Over CA$30M [Yahoo! Finance]Yahoo! Finance
- Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity [Yahoo! Finance]Yahoo! Finance
- What Makes Exelixis (EXEL) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]Yahoo! Finance
EXEL
Earnings
- 10/29/24 - Beat
EXEL
Sec Filings
- 11/19/24 - Form 4
- 11/19/24 - Form 4
- 11/19/24 - Form 4
- EXEL's page on the SEC website